Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5387_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Foreword
- •Preface
- •About the Editors
- •Contributors
- •References
- •2.3.4 Barriers to Automation Adoption
- •2.4 Core Ingredients for Successful Digital Transformation
- •2.1 Introduction
- •2.3.1 Operational Challenges
- •2.3.2 Cultural Challenges
- •2.4.2 Cloud Computing
- •2.5 Case Studies of Successful Digital Transformation
- •2.6 Conclusion
- •References
- •3. Computational Protein Design Strategies for Optimization of Antigen Generation to Drive Antibody Discovery
- •3.1 Introduction
- •3.3 Antigen Generation Strategies
- •3.4 Computational Methods
- •3.4.2 Computational Protein Structure Prediction
- •References
- •4. Bioinformatic Analyses of Antibody Repertoires and Their Roles in Modern Antibody Drug Discovery
- •4.1 Introduction
- •4.6 Summary and Future Directions
- •Acknowledgments
- •References
- •5.1 Introduction
- •5.2 Databases
- •5.2.1 Databases in Machine Learning Approaches
- •5.2.2 Database Types
- •5.3 Applications of Machine Learning in Antibody Discovery and Development
- •5.3.1 Structure Prediction with Deep Learning
- •5.3.3 Developability
- •5.4 Antibody Generation and Design by Language Models
- •5.4.1 Antibody Representations
- •5.4.2 Representation Learning
- •5.4.3 Language Models
- •References
- •6.1 Introduction
- •6.2 Antibody Generation through Deep Generative Models
- •6.3.1 Sampling and Scoring
- •6.5 Conclusions and Perspectives
- •Acknowledgments
- •References
- •7.1 Introduction
- •7.2.3 Computational Approaches to Predict Antibody–Antigen Interaction
- •7.3 Conclusion
- •Competing Interests
- •Acknowledgments
- •References
- •8.2 Common Types of Molecular Simulations for Biomolecules
- •8.2.1 Molecular Dynamics (MD) Simulations
- •8.2.2 Monte Carlo (MC) Simulations
- •8.2.3 Challenges of Molecular Simulations
- •8.3.1 Periodic Boundary Conditions
- •8.4 Uses of Molecular Simulation in Antibody Drug Development
- •8.5 Conclusion
- •References
- •9. Considerations of Developability During the Early Stages of Antibody Drug Discovery and Design
- •9.1 Introduction
- •9.2 Historical Perspective
- •9.3 Clinical Antibody Data Set
- •9.5 Control Antibodies
- •9.7 Assessment of Chemical Liabilities
- •9.8 Conclusions and Future Perspectives
- •Acknowledgments
- •References
- •Abbreviations
- •10.1 Introduction
- •10.4.1 Conclusions and Outlook
- •Acknowledgments
- •References
- •11.8 Conclusions and Future Directions
- •References
- •12.1 Introduction to PK/PD and QSP Modeling
- •12.1.1 PK/PD Modeling
- •12.1.2 QSP Modeling
- •12.2.1 Monoclonal Antibodies (mAbs)
- •12.2.3 Cell Therapies
- •12.2.4 Gene Therapies
- •12.2.5 Vaccines
- •12.2.6 mRNA/siRNA/Oligonucleotide Therapeutics
- •12.4 Case Studies
- •12.5 Conclusions and Future Perspectives
- •References
- •13.1 Introduction
- •13.2 AI/ML: A Game Changer for Antibody Design
- •13.3 Multispecific Antibody Design
- •13.4 Adapting AI to the Design of Multispecific Antibodies
- •13.4.1 Structure Prediction and Modeling
- •13.4.2 Developability Prediction and Optimization
- •13.4.4 In Silico Modeling and Simulation
- •13.5 The Future: Beyond Optimization
- •13.5.1 Market Trends and Commercialization
- •13.5.2 Logic Gates, Biosensors, and De Novo Design
- •13.5.3 Challenges and Opportunities
- •13.6 Conclusion
- •Acknowledgments
- •References
- •Index

7 • Antibody Structure‑Function 171
residues using 120 properties calculated from the antibody–antigen complexes. It also
allows an optional additional step of nding surface patches on antigens with high scores
(termed patch scores). Another study combined statistical and ML algorithms to predict
the antibody‑specic epitopes. They calculated several geometric and physicochemi‑
cal features related to interacting regions of antibody–antigen complexes. These fea‑
tures were used in Monte Carlo algorithms to generate putative epitope–paratope pairs,
used as training datasets in the ML model (Jespersen etal., 2019). A DL‑based frame‑
work, “Paratope and Epitope prediction with graph Convolution Attention Network”
(PECAN), uses a protein–protein interaction dataset for training and utilizes transfer
learning to predict the binding interface of antibody–antigen complexes. The local resi‑
dues at close spatial proximity of the interfaces were captured using graph convolutions,
while an attention layer was employed to encode antibody–antigen pair interactions
(Pittala & Bailey‑Kellogg, 2020).
A protein–protein interaction prediction method, “Molecular Surface Interaction
Fingerprints” (MaSIF), applies geometric deep learning (GDL), which can incorporate
geometric features such as structure and symmetry of the input to improve the quality
of the predictions (Gainza etal., 2020). MaSIF also uses antibody–antigen complexes as
training data. MaSIF converts the protein surface into a mesh representation, where each
vertex contains two geometric features (shape and distance‑dependent curvature) and
three chemical features (hydropathy, continuum electrostatics, and location of free elec‑
trons/proton donors). Furthermore, a set of geodesic lters generates an output with a xed
dimension. The performance of MaSIF showed an ROC AUC of 0.77 with one geodesic
convolutional layer and 0.86 with three layers. A simple version of this GDL model, dif‑
ferentiable molecular surface interaction ngerprinting (dMaSIF), is also now available
for large‑scale analysis with simplied surface representation (Sverrisson etal., 2020).
Del Vecchio etal. (2021) argued that paratope and epitope prediction require asymmetric
treatment. Therefore, they developed a separate paratope model (Para‑EPMP) and epit‑
ope model (Epi‑EPMP) for joint paratope and epitope prediction. Rangel etal. utilized a
fragment‑based approach for the combinatorial design of antibody binding loops (CDRs)
and grafted them onto antibody scaffolds (Rangel etal., 2021). The designed CDRs were
also computationally optimized for solubility and conformational solubility.
7.2.4 In Silico Prediction of Binding Afnity
Understanding protein–protein interactions is crucial in the investigation of biological
systems, as these play a critical role in almost all cellular processes (Gromiha, 2020;
Jones & Thornton, 1996; Perkins etal., 2010). Binding afnity is dened as the strength
of interaction between proteins and/or peptides. However, higher binding afnity does
not always lead to the best therapeutic response (Yu etal., 2023). The binding afnity
of an interaction is described through the equilibrium dissociation constant KD, or, in
thermodynamic terms, the Gibbs free energy ΔG (ΔG = -RT ln KD) (Kastritis & Bonvin,
2013). Experimentally measuring KD values is a time‑consuming and expensive process
(Jarmoskaite etal., 2020). Therefore, many computational methods have been developed
for predicting the binding afnity (Table7.3). Binding afnity prediction is important
because it not only allows to control interactions and develop innovative therapeutics but

TABLE7.3 List of computational resources available for the prediction of the absolute value of binding afnity and change in binding
afnity upon mutation(s)
BINDING AFFINITY PREDICTION TOOLS
METHOD FEATURES PERFORMANCE MODEL TYPE TRAINED ON
AB‑AG DATA?
1. Sequence‑Based Prediction Methods
PPA-Pred Sequence-based afnity
prediction using functional
information
ISLAND Kernel representation r = 0.44 on
PIPR Pre-trained embeddings r = 0.87 on
RAPPPID Pairs of amino acid sequences r = 0.97 on
TcellMatch Sequence embedding r = 0.63 on 10x
r = 0.90 on 135
complexes
selected from
structure-based
benchmark
structure-based
benchmark
SKEMPI
STRING
dataset
Regression Yes (11.1%;
15 out of
135)
Support vector machine
(SVM)
RRCNN Yes (11.02%;
Neural network Yes (2.6%;
Neural network Yes (100%;
Yes (11.1%;
15 out of
135)
781 out of
7,085)
242 out of
9,340)
4,812)
URL/REFERENCE
https://www.iitm.ac.in/
bioinfo/PPA_Pred/
(Yugandhar & Michael
Gromiha, 2014)
https://sites.google.com/
view/wajidarshad/software
(Abbasi etal., 2020)
https://github.com/
muhaochen/seq_ppi (Chen
etal., 2019)
https://github.com/jszym/
rapppid (Szymborski &
Emad, 2022)
(Fischer etal., 2020)
172 Biopharmaceutical Informatics
(Continued)

TABLE7.3 (Continued ) List of computational resources available for the prediction of the absolute value of binding afnity and change in
binding afnity upon mutation(s)
BINDING AFFINITY PREDICTION TOOLS
METHOD FEATURES PERFORMANCE MODEL TYPE TRAINED ON
AB‑AG DATA?
Structure‑Based Prediction Methods
2.
PRODIGY Inter‑residue contacts and
noninteracting surface
FoldX Empirical function 64% Empirical function No https://foldxsuite.crg.eu/
PPI‑Afnity ProtDcal r = 0.77 on the
CSM‑AB Graph‑based signatures r = 0.64 on
r = 0.73 on
benchmark of
81 protein–
protein
complexes
PDBbind
database
PDBbind,
SabDab, RCSB
PDB
Linear regression Yes (14.8%;
12 out of 81)
SVM Yes (9.8%; 82
out of 833)
Regression Yes (100%;
472)
URL/REFERENCE
https://wenmr.science.uu.nl/
prodigy/ (Xue etal., 2016)
(Delgado etal., 2019)
https://protdcal.zmb.uni‑due.
de/PPIAfnity*
(Romero‑Molina etal.,
2022)
http://biosig.unimelb.edu.au/
csm_ab/prediction (Myung
etal., 2022)
(Continued)
7 • Antibody Structure‑Function 173

TABLE7.3 (Continued ) List of computational resources available for the prediction of the absolute value of binding afnity and change in
binding afnity upon mutation(s)
BINDING AFFINITY PREDICTION TOOLS
METHOD FEATURES PERFORMANCE MODEL TYPE TRAINED ON
AB‑AG DATA?
Change in Binding Afnity Upon Mutation Prediction Tools
1. Sequence‑Based Prediction Methods
ProAfMuSeq Sequence-based features and
functional class
PANDA Sequence-based r = 0.52 on
SAAMBE-SEQ Sequence-based, physical
properties
2. Structure‑Based Prediction Methods
BeAtMuSic Statistical potentials r = 0.4 on
BindProfX Interface prole score, shape
complementarity, and
sequence-based features
r = 0.73 on
mutation data
from
PROXiMATE
SKEMPI 2.0
r = 0.83 on
SKEMPI 2.0
SKEMPI
r = 0.68 on
SKEMPI
Regression Yes (16.1%;
189 out of
1,173)
Regression Yes (11.02%;
781 out of
7,085)
Gradient-boosting
decision tree
Regression Yes (1.8%; 55
Prole score Yes (1.8%; 55
Yes (11.02%;
781 out of
7,085)
out of 3,047)
out of 3,047)
URL/REFERENCE
https://web.iitm.ac.in/
bioinfo2/proafmuseq/
(Jemimah etal., 2019)
https://github.com/
wajidarshad/panda (Abbasi
etal., 2021)
http://compbio.clemson.edu/
saambe_webserver/
indexSEQ.php#started (Li
etal., 2021)
http://babylone.ulb.ac.be/
beatmusic/index.php
(Dehouck etal., 2013)
https://zhanggroup.org/
BindProfX/ (Xiong etal.,
2017)
174 Biopharmaceutical Informatics
(Continued)

TABLE7.3 (Continued ) List of computational resources available for the prediction of the absolute value of binding afnity and change in
binding afnity upon mutation(s)
BINDING AFFINITY PREDICTION TOOLS
METHOD FEATURES PERFORMANCE MODEL TYPE TRAINED ON
AB‑AG DATA?
URL/REFERENCE
SAAMBE Van der Waals, solvation and
Coulomb energy, entropy,
hydrophobicity, solvent
accessible surface area,
hydrogen bonds and
interface area
MutaBind Van der Waals energy,
solvation energy, free energy
change due to unfolding,
solvent accessible surface
area
mmCSM-PPI Graph-based signatures and
complementary features
r = 0.82 on
SKEMPI 2.0
r = 0.68 on
SKEMPI
r = 0.75 on
SKEMPI 2.0
XGBoost Yes (11.02%;
781 out of
7,085)
Molecular mechanics
force elds, statistical
potentials, and fast
side-chain optimization
algorithms
Extra trees Yes (11.02%;
Yes (1.8%; 55
out of 3,047)
781 out of
7,085)
http://compbio.clemson.edu/
saambe_webserver/ (Li
etal., 2021)
7 • Antibody Structure-Function 175
https://lilab.jysw.suda.edu.cn/
research/mutabind2// (Li
etal., 2016)
https://biosig.lab.uq.edu.au/
mmcsm_ppi/ (Rodrigues
etal., 2021)
(Continued)

TABLE7.3 (Continued ) List of computational resources available for the prediction of the absolute value of binding afnity and change in
binding afnity upon mutation(s)
BINDING AFFINITY PREDICTION TOOLS
METHOD FEATURES PERFORMANCE MODEL TYPE TRAINED ON
AB‑AG DATA?
URL/REFERENCE
176 Biopharmaceutical Informatics
GeoPPI Graph neural network r
TopNetTree CNN, persistent homology r = 0.79 on
PerSpect‑EL Physical properties, persistent
homology
mCSM‑AB Graph‑based signatures r = 0.53 on 29
FoldX Empirical function 64% Empirical function No https://foldxsuite.crg.eu/
The links that are not active (as checked on Dec 2024) are denoted with “*” sign.
= 0.52 on
SKEMPI 2.0
SKEMPI 2.0
r = 0.85 on
SKEMPI 2.0
Ab‑Ag
complexes
Gradient‑boosting tree Yes (11.02%;
781 out of
7,085)
Gradient‑boosting tree Yes (11.02%;
781 out of
7,085)
CNN+gradient‑boosting
tree
Regression Yes (100%;
Yes (11.02%;
781 out of
7,085)
645)
https://github.com/Liuxg16/
GeoPPI (Liu etal., 2021)
(Wang etal., 2020)
https://github.com/
ExpectozJJ/
PerSpect‑Ensemble‑Learning
(Wee & Xia, 2022)
https://biosig.lab.uq.edu.au/
mcsm_ab/prediction (Pires &
Ascher, 2016)
(Delgado etal., 2019)

7 • Antibody Structure-Function 177
also for other applications such as protein engineering, computational mutagenesis, and
docking (Ben‑Shimon & Eisenstein, 2010; Keskin etal., 2005; Kortemme etal., 2004;
Vangone & Bonvin, 2015).
7.2.4.1 Binding afnity prediction methods
There are several sequence‑based binding afnity prediction methods available for
protein–protein complexes. Protein‑Protein Afnity Predictor (PPA‑Pred), a tool for
predicting the real value of binding afnity from amino acid sequences, is based on a
multiple regression model (Yugandhar & Michael Gromiha, 2014). The sequence‑based
features include predicted binding site residues and property values of 20 amino acids
from the AAindex database (Kawashima, 2000). The training data included antibody–
antigen complexes as well and showed a correlation from 0.74 to 0.99 for different classes
of complexes. ISLAND (In SiLico protein AfNity preDictor), another sequence‑based
tool, combined a kernel representation of protein sequences with the support vector
regression to predict the binding afnity. The correlation between the experimental and
predicted ΔG was 0.44, and the structure‑based benchmark for protein–protein bind‑
ing afnity data was used (Abbasi etal., 2020). Another tool based on the recurrent
convolutional neural network (RCNN) that takes amino acid sequence as the input for
prediction of protein–protein binding afnity was developed by Chen etal. (2019). The
correlation of 0.87 was obtained from a Siamese residual RCNN with a pre‑trained
embedding representation of protein sequences. A similar model known as DPPI was
developed by Hashemifar et al., which was based on DL model (Hashemifar et al.,
2018). Another end‑to‑end DL framework that learns both robust local features and
contextualized information from sequences is Protein–Protein Interaction Prediction
Based on Siamese Residual RCNN (PIPR), which was able to predict the binding afni‑
ties between the interacting proteins (Chen etal., 2019). Moreover, a method named
regularized automatic prediction of PPIs using deep learning (RAPPPID) was trained
by considering pairs of amino acid sequences of interacting proteins and allowing better
distinctiveness between the interacting motifs and other parts of the proteins. Further,
Xue etal. developed a method based on pre‑trained embedding; and residual RCNN,
structure information, and functions of proteins were used in the pre‑training stage to
generate sequence embeddings. However, the performance of the model was poor with a
correlation of only 0.26 (Xue etal. 2021). Fischer etal considered the UMI counts in 10x
Genomics single‑cell immune proling dataset as binding strength of the TCR‑pMHC
complex and developed a model named “TcellMatch” with r2 values of 0.63 (Fischer
etal., 2020). Makowski etal. combined high‑throughput experimental methods includ‑
ing deep sequencing and ML to identify therapeutic antibody variants with superior
combinations of afnity and non‑specic binding (Makowski etal., 2022). The model is
trained on binary datasets for afnity and specicity and does not consider real binding
afnity prediction, yet it correlates with continuous afnity values. A similar approach
is also used in the pipeline called RESP that is trained on over 3million human B‑cell
receptor sequences. The pipeline efciently identies the high‑afnity antibodies
but is not designed to predict binding afnity (Parkinson etal., 2023). Bachas et al.
(2022) used deep contextual language models trained on high‑throughput afnity data
to quantitatively predict binding of unseen antibody sequence variants and included a

178 Biopharmaceutical Informatics
metric to score antibody variants for similarity to natural IGs. It is important to note
that sequence‑based methods are unable to perform predictions for different binding
poses of the interacting proteins and do not take conformational changes into account
(Gromiha etal., 2017).
The structure‑based methods have signicant advantages over sequence‑based pre‑
diction. However, they usually lack the high‑quality structural data. The rst study to
relate binding afnities with a set of structures was by Horton and Lewis who used 15
ΔG values from literature as training data and used interface polar and non‑polar groups
as features to obtain a linear regression coefcient of r = 0.96, and a mean absolute
difference of 0.8 kcal/mol between the calculated and observed ΔG values (Horton &
Lewis, 1992). Kastritis etal. (2011) benchmarked the protein–protein binding afnity
data for 144 protein–protein complexes (including 19 antibody–antigen complexes) with
varying biological functions and observed that the performance was poor on a validation
set because of noise in the experimental data (Kastritis & Bonvin, 2011). Faster methods
based on empirical functions (empirical, force‑eld‑based potentials, statistical poten‑
tials, and scoring functions used in docking) could be successful on small training sets
(Audie & Scarlata, 2007; Horton & Lewis, 1992) but most of them fail to predict bind‑
ing afnity accurately (Rosato, 2010) for large datasets or discriminate between binders
and non‑binders (Sacquin‑Mora etal., 2008). Vangone and Bonvin (2015) worked on
relating the interfacial contacts (ICs) and noninteracting surface (NIS) residues with the
experimental binding afnity and obtained a Pearson correlation of −0.73. They used a
training dataset of 81 protein–protein complexes (including ten antibody–antigen com‑
plexes) and developed a method, PROtein binDIng enerGY prediction (PRODIGY), that
can predict the binding afnity of protein–protein complexes from their 3D structure
with a correlation of 0.73 between experimental and predicted ΔG values (Vangone &
Bonvin, 2015; Xue etal., 2016). Vangone and Bonvin (2015) further analyzed 122 com‑
plexes with binding afnity data and observed that structure‑based methods such as free
energy perturbation and thermodynamics integration could be very accurate, but due to
their computational costs, their application is extremely limited. Apart from regression
models, QSAR models were also used for relating structural descriptors with binding
afnity of protein–protein complexes using structure‑based benchmark datasets com‑
piled by Kastritis etal. (2011) and Zhou etal. (2013). Using the same dataset Marillet
etal. (2016) utilized 12 features which account for enthalpic and entropic changes upon
binding and devised protein–protein afnity prediction models. Wang etal. used the
knowledge‑based potentials and reformulated the binding afnity based on the Monte
Carlo algorithm to obtain a Pearson correlation of 0.7 for the prediction (Wang, Su,
etal., 2021). FoldX by Delgado etal. (2019) uses an empirical function for predicting
the binding free energy between the protein–protein complexes.
In recent years, ML methods have been developed which are faster and more accu‑
rate for predicting protein–protein binding afnity (Li etal., 2022). PPI‑Afnity is a
web‑based tool that predicts the binding afnity using support vector machines and
other classic ML models (Romero‑Molina etal., 2022). The ML model showed a per‑
formance of r = 0.77 on the SKEMPI dataset (Romero‑Molina etal., 2022). In addition,
a few antibody–antigen‑specic binding afnity prediction methods have also been
developed in the past few years. CSM‑AB developed by Myung etal. (2022) is a ML
method capable of predicting antibody–antigen binding afnity by modeling interaction

7 • Antibody Structure-Function 179
interfaces as graph‑based signatures. It obtained a correlation of up to 0.64 on a blind
test dataset. Yang etal. carried out a ML analysis based on interface and surface areas
for antibody–antigen complexes. They constructed different models to predict anti‑
body–antigen binding using area‑based and contacts‑based descriptors through con‑
structing and training different predictive models. They obtained the best correlation of
0.85 (with 33 antibody–antigen complexes) and 0.74 (with 262 antibody–antigen com‑
plexes). Their results showed that the area‑based descriptors are slightly better than
the contacts‑based descriptors in terms of predictive power; the new models specic
for antibody‒protein antigen binding afnity prediction are superior to the previously
used general models for predicting the protein–protein binding afnities; and the per‑
formances of the best area‑based and contacts‑based models are better than the perfor‑
mances of the graph‑based model (i.e., CSM‑AB) specic for antibody–antigen binding
afnity prediction (Yang etal., 2023). Recently, Sharma et al. developed a model for
predicting the binding afnity for SARS‑CoV‑2 spike protein and neutralizing antibod‑
ies using 29 antibody–antigen complexes. They obtained a correlation of 0.90 for the
jack‑knife test on SARS‑CoV‑2 protein data bank structures (Sharma etal., 2022).
7.2.4.2 Change in binding afnity upon
mutation prediction methods
Mutations in a protein cause changes in its structure, function, interactions, and binding
afnity, which can lead to disease (Gromiha et al., 2016). Several methods have been
developed over the years for the prediction of change in binding afnity upon mutation
utilizing sequence, structure, and energy‑based features as well as a combination of them.
BeAtMuSiC is a coarse‑grained predictor of the changes in binding free energy induced
by point mutations. It is based on a set of statistical potentials derived from known protein
structures and integrates the mutation’s effect on: (i) the strength of the interactions at
the interface, and (ii) the overall stability of the complex (Dehouck etal., 2013). The cor‑
relation obtained by BeAtMuSiC with 90% of the SKEMPI dataset (including antibody–
antigen complexes) was 0.70. Brender etal. used random forest training and combined
interface structure prole scores with residue‑level coarse‑grained potentials to develop
a composite predictive model. They obtained a correlation of >0.8 between the predicted
and observed binding free energy changes upon mutation using the SKEMPI database
(Jankauskaitė etal., 2018). The single amino acid mutation‑based change in binding free
energy (SAAMBE) method developed by Petukh et al. (2015) took advantage of both
sequence and structure‑based methods and utilized structure minimization, statistical
energy scoring functions, and modied molecular mechanics energies combined with
the Poisson–Boltzmann surface area continuum solvation (MM‑PBSA) for estimat‑
ing the effect of single and multiple mutations on binding afnity. The mmCSM‑PPI,
developed by Rodrigues et al. (2021), predicts binding afnity change upon mutation
using graph‑based signatures, which describe the distance patterns between atoms on the
binding interface (Rodrigues etal., 2021). Another method that depends on graph‑based
signatures is mCSM‑AB, which is specic for predicting antibody–antigen afnity
changes upon mutation (Pires & Ascher, 2016). Methods such as GeoPPI, TopNetTree,
and PerSpect‑EL are based on neural networks and persistent homology (Liu etal., 2021;
Wang etal., 2020; Wee & Xia, 2022). All these methods used the SKEMPI dataset

180 Biopharmaceutical Informatics
and showed a correlation of up to 0.85 between predicted and experimental data. FoldX
software can also evaluate the effect of mutations on protein stability, interaction, fold‑
ing, and dynamics using structures (Delgado etal., 2019). Jemimah et al. developed
ProAfMuSeq, a method that predicts protein–protein binding afnity change upon
mutation using sequence‑based features and functional class. It shows a correlation of
0.73 and a mean absolute error (MAE) of 0.86 kcal/mol in cross‑validation (Jemimah
etal., 2019). Another sequence‑based predictor is PANDA that could predict a change
in protein binding afnity upon mutation with a correlation coefcient of 0.52 (Abbasi
etal., 2021). SAAMBE‑SEQ is based on a gradient‑boosting decision tree ML algorithm.
It utilized 80 features representing evolutionary information, sequence‑based features,
and change of physical properties upon mutation at the mutation site and achieved a
Pearson correlation coefcient (PCC) of 0.83 (Li etal., 2021).
7.2.5 Biophysical Parameters Affecting
Antibody Design
There are certain biophysical parameters which need consideration for the optimization
of binding afnity, specicity, and developability of an antibody (Khetan etal., 2022).
These parameters include variations of protein features such as charge, pH/isoelectric
point, hydrophobicity, and CDR length and are calculated for either the whole antibody
or a specic region of the antibody. The rst developability guidelines were dened
using 137 clinical‑stage antibodies, which empirically dene boundaries of antibody
drug‑like behavior (Jain etal., 2017). Further, Raybould etal. presented ve biophysical
parameters for antibodies similar to the “Lipinski rule of ves” for orally active drugs,
which include CDR length, surface hydrophobicity of the near CDR region, and three
charge‑based metrics (patches of positive charge, patches of negative charge near the
CDR region, and charge symmetry of the surface exposed residues) (Raybould etal.,
2019). More recently, in silico analyses of the variable regions of 77marketed anti‑
body‑based biotherapeutics have revealed ve non‑redundant physicochemical descrip‑
tors, which represent stability, isoelectric point, and molecular surface characteristics
of Fv regions (Ahmed etal., 2021). Another study on the same dataset found that anti‑
body specicity is dependent on the net charge of CDR regions, with positively charged
CDRs having a higher risk of low specicity than negatively charged antibodies (Rabia
etal., 2018). Negatively charged CDRs were also linked with the poor biophysical prop‑
erties of the antibody. Bashour etal. (2024) conducted a computational assessment of
40 sequence‑based and 46 structure‑based developability parameters (DPs) across more
than two million native and human‑engineered single‑chain antibody sequences. Their
analysis revealed that structure‑based DPs exhibited lower redundancy compared to
sequence‑based DPs, suggesting that sequence DPs are more predictable and oper‑
ate within a more constrained design space. Sharma et al. looked into the viscosity
and clearance of antibodies (Sharma etal., 2014). They observed that antibody viscos‑
ity increases with the increase in charge dipole distribution and hydrophobicity, and
decreases with net charge. On the other hand, antibody clearance correlates with high
hydrophobicity of CDR regions and highly positive/negative net charge. An analysis
of a small set of FDA‑approved antibodies revealed that the shift in isoelectric point,
Соседние файлы в папке Библиотека им академика М.И. Перельмана
